Do you have cancer with a MET alteration?
Learn about an investigational drug designed to target the c-Met pathway
and slow tumor growth in the SPARTA study. If you have non-small cell lung cancer (NSCLC), brain cancer, or another advanced solid tumor
, you may qualify.
Do I Qualify?